No black box warning on record for Enalapril Maleate And Hydrochlorothiazide

As of the latest FDA labeling reviewed, Enalapril Maleate And Hydrochlorothiazide (ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Enalapril Maleate And Hydrochlorothiazide medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS General Enalapril Maleate Hypotension Excessive hypotension was rarely seen in uncomplicated hypertensive patients but is a possible consequence of enalapril use in severely salt/volume depleted persons such as those treated vigorously with diuretics or patients on dialysis. Syncope has been reported in 1.3 percent of patients receiving enalapril maleate and hydrochlorothiazide. In patien

No black box warning on record for Enalapril Maleate And Hydrochlorothiazide

Other warnings & precautions

WARNINGS General Enalapril Maleate Hypotension Excessive hypotension was rarely seen in uncomplicated hypertensive patients but is a possible consequence of enalapril use in severely salt/volume depleted persons such as those treated vigorously with diuretics or patients on dialysis. Syncope has been reported in 1.3 percent of patients receiving enalapril maleate and hydrochlorothiazide. In patien

Enalapril Maleate And Hydrochlorothiazide Black Box Warning

No black box warning on record for Enalapril Maleate And Hydrochlorothiazide

Other warnings & precautions

Enalapril Maleate And Hydrochlorothiazide Black Box Warning

No black box warning on record for Enalapril Maleate And Hydrochlorothiazide

Other warnings & precautions